KALA BIO, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by KALA BIO, Inc. on September 9, 2026. The filing announces the establishment of the date for the Company's next Annual Meeting of Stockholders and sets deadlines for shareholder proposals and director nominations.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance.
Material Changes
The primary material change is the scheduling of the Annual Meeting for November 3, 2026. This date represents a change of more than 30 calendar days from the anniversary of the last annual meeting, triggering specific deadlines for shareholder communications.
Guidance, Outlook, and Management Commentary
- Annual Meeting Date: November 3, 2026.
- Shareholder Proposal Deadline (Rule 14a-8): Proposals must be received by September 19, 2026.
- Director Nomination Deadline: Notices must be received by September 19, 2026, in accordance with the Company's By-Laws.
- Future Communications: Additional details regarding the time, location, and matters to be voted on will be published in the proxy statement.
Key Facts for Investor Verification
- Verify the exact time and location of the Annual Meeting once the proxy statement is released.
- Confirm the specific requirements for director nominations under the Third Amended and Restated By-Laws.
- Note the September 19, 2026 deadline for submitting any shareholder proposals or director nominations.
- Review the upcoming proxy statement for the full list of matters to be voted upon.